Lv2
190 积分 2023-03-14 加入
Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma
1个月前
已完结
Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma
1个月前
已完结
Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours
1个月前
已完结
REAL-TIME, LABEL-FREE ASSESSMENT OF HER2-TARGETED ANTIBODY-DRUG CONJUGATE THERAPIES
2个月前
已完结
Design and Synthesis of Novel 6,7‐Dihydrobenzo[d]isoxazol‐4(5H)‐one Derivatives Bearing 1,2,3‐Triazole Moiety as Potential Hsp90 Inhibitors and their Evaluation as Antiproliferative Agents
3个月前
已完结
Design, synthesis and application of spiro[4.5]cyclohexadienones via one-pot sequential p-hydroxybenzylation/oxidative dearomatization
3个月前
已完结
Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
3个月前
已完结
Antibody–drug conjugates come of age in oncology
3个月前
已完结
Platinum(IV) Complexes Trigger Death Receptors and Natural Killer Cells to Suppress Breast Cancer
3个月前
已完结
Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody–Drug Conjugate for Treatment of CLDN18.2-Positive Cancers
3个月前
已完结
皖公网安备34019202002308
